Literature DB >> 1677602

The myth of elevated serum creatine phosphokinase level and neuroleptic malignant syndrome.

.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1677602     DOI: 10.1192/bjp.158.5.706

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN: 0007-1250            Impact factor:   9.319


× No keyword cloud information.
  6 in total

1.  Aripiprazole as the causative agent of neuroleptic malignant syndrome: a case report.

Authors:  Daniel Molina; Leslie E Tingle; Xiaohui Lu
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2007

2.  How "malignant" is the neuroleptic malignant syndrome?

Authors:  M F Bristow; D Kohen
Journal:  BMJ       Date:  1993-11-13

Review 3.  Antipsychotic-induced elevation of creatine kinase: a systematic review of the literature and recommendations for the clinical practice.

Authors:  Zacharias G Laoutidis; Kanellos T Kioulos
Journal:  Psychopharmacology (Berl)       Date:  2014-10-16       Impact factor: 4.530

4.  Neuroleptic malignant syndrome and catatonia. A report of three cases.

Authors:  M Raja; M C Altavista; S Cavallari; L Lubich
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1994       Impact factor: 5.270

Review 5.  Neuroleptic malignant syndrome: an easily overlooked neurologic emergency.

Authors:  Ramadhan Oruch; Ian F Pryme; Bernt A Engelsen; Anders Lund
Journal:  Neuropsychiatr Dis Treat       Date:  2017-01-16       Impact factor: 2.570

Review 6.  A Case Report of Catatonia and Neuroleptic Malignant Syndrome With Multiple Treatment Modalities: Short Communication and Literature Review.

Authors:  Yu-Jie Chiou; Yu Lee; Chin-Chuen Lin; Tiao-Lai Huang
Journal:  Medicine (Baltimore)       Date:  2015-10       Impact factor: 1.817

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.